Skip to main content
Fig. 1 | Journal of Inflammation

Fig. 1

From: IL-35 alleviates inflammation progression in a rat model of diabetic neuropathic pain via inhibition of JNK signaling

Fig. 1

Effect of IL-35 on inflammation in a rat model of DNP. The fasting insulin concentration using ELISA assay (a), Changes in MWT and TWL (b) in baseline, after 14 days of intraperitoneal injection with STZ and after administrating different drugs for 1, 3, 7 and 14 days and serum levels of IL-35 (c), IL-1β (d), IL-6 (e) and TNF-α (f) and IL-10 (g) in the groups of Control, DNP, DNP + vehicle, SP, IL-35 and IL-35 + Ani. *P < 0.05 vs. the control group; #P < 0.05 vs. the DNP + vehicle group; $P < 0.05 vs. the IL-35 group. n = 6 per group

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us